Patents by Inventor Cecile CROS

Cecile CROS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Nicotinamide Mononucleotide Derivatives And Use Thereof In The Treatment And Prevention Of A Red Blood Cell Disorder
    Publication number: 20230355650
    Abstract: The present invention relates to nicotinamide mononucleotide derivatives of Formula (I) for use in the treatment and/or prevention of a blood disorder, especially sickle cell disease. The present invention further relates to pharmaceutical compositions comprising compounds of Formula (I) for use in the treatment and/or prevention of a red blood cell disorder, especially sickle cell disease.
    Type: Application
    Filed: July 13, 2023
    Publication date: November 9, 2023
    Inventors: Guillaume BERMOND, Laurent GARÇON, Matthias CANAULT, Cecile CROS
  • NICOTINAMIDE MONONUCLEOTIDE DERIVATIVES AND USE THEREOF IN THE TREATMENT AND PREVENTION OF A RED BLOOD CELL DISORDER
    Publication number: 20230330124
    Abstract: The present disclosure relates to nicotinamide mononucleotide derivatives of Formula (I) for use in the treatment and/or prevention of a blood disorder, especially sickle cell disease. The present disclosure further relates to pharmaceutical compositions including compounds of Formula (I) for use in the treatment and/or prevention of a red blood cell disorder, especially sickle cell disease.
    Type: Application
    Filed: December 17, 2021
    Publication date: October 19, 2023
    Applicant: Nuvamid SA
    Inventors: Guillaume BERMOND, Laurent GARÇON, Matthias CANAULT, Cecile CROS
  • COMPOSITION MODULATING BOTULINUM NEUROTOXIN EFFECT
    Publication number: 20230018920
    Abstract: The present invention relates to a method for modulating the effect of a botulinum neurotoxin composition, that is accelerating the onset of action and/or extending the duration of action and/or enhancing the intensity of action of a botulinum neurotoxin composition, comprising adding at least one postsynaptic inhibitor of cholinergic neuronal transmission to the botulinum neurotoxin composition. The invention also relates to compositions comprising at least one postsynaptic inhibitor of cholinergic neuronal transmission and a botulinum neurotoxin, and their uses for treating aesthetic or therapeutic conditions.
    Type: Application
    Filed: June 22, 2020
    Publication date: January 19, 2023
    Inventors: Jean-Marc LE DOUSSAL, Cecile CROS, Nicolas HULO, Mickael COANE